Making your project a commercial success
Nycomed is a truly global pharmaceutical company with products available in over 100 countries. We have a major presence in Europe and in key emerging markets like Russia/CIS and Latin America. Our geographical footprint makes us the ideal partner for companies seeking to market their products outside the United States.
Our global commercial operations have extensive experience in both general practitioner and specialist markets. We have affiliates in over 50 countries and a successful history of brand building and commercialisation to excel in complex markets.
Nycomed’s R&D is organised to meet specific needs for partnering projects and the way we are structured ensures that external projects have the same priority as internal projects. With over 1,000 scientists, we provide full R&D capabilities from early stage development right through to lifecycle management. We also have recognised strength in navigating the European and US regulatory system.
Our flexible set-up means that we can work effectively with suitable partners at every stage of development and we are fully equipped to add value to our partners’ projects.
From experience, we know that a successful partnership is not simply a matter of complementary competences and compatible processes. Partnerships function well when people know how to work together openly and with trust.
That is why Nycomed has established a dedicated global Alliance Management group working on maintaining our partnerships and collaborations. Alliance Management is the collection of activities necessary to making an alliance work well and maximize the potential of every alliance based upon aligned goals, respectful and open communication as well as transparent commitment management.
Local licensing
Nycomed’s product portfolio is extensive and highly adapted to suit local needs and requirements. To meet regional and local demand, we are seeking new licensing opportunities on marketed products wherever we operate.
Early Alliances
Partnering at Nycomed starts at all stages. Nycomed’s discovery and pre-clinical development organisation is actively looking for opportunities to collaborate with external partners even at very early stages of discovery. Joint development of innovative ideas and therapeutic concepts can start as early as the definition of validated targets, therapeutic intervention strategies, or lead structures.